BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30825264)

  • 1. GAEC1 drives colon cancer progression.
    Lee KT; Vider J; Tang JC; Gopalan V; Lam AK
    Mol Carcinog; 2019 Jul; 58(7):1145-1154. PubMed ID: 30825264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular expression, in-vitro and in-vivo confirmation of GAEC1 oncogenic properties in colon cancer.
    Wahab R; Gopalan V; Islam F; Smith RA; Qiao B; Lam AK
    Eur J Cell Biol; 2017 Sep; 96(6):487-495. PubMed ID: 28764863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of GAEC1 mRNA and protein and its association with clinical and pathological parameters of patients with colorectal adenocarcinoma.
    Wahab R; Gopalan V; Islam F; Mamoori A; Lee KT; Lu CT; Lam AK
    Exp Mol Pathol; 2018 Feb; 104(1):71-75. PubMed ID: 29337242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features.
    Gopalan V; Smith RA; Nassiri MR; Yasuda K; Salajegheh A; Kim SY; Ho YH; Weinstein S; Tang JC; Lam AK
    Hum Pathol; 2010 Jul; 41(7):1009-15. PubMed ID: 20236690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAEC1 mutations and copy number aberration is associated with biological aggressiveness of colorectal cancer.
    Lee KT; Gopalan V; Islam F; Wahab R; Mamoori A; Lu CT; Smith RA; Lam AK
    Eur J Cell Biol; 2018 Apr; 97(3):230-241. PubMed ID: 29555101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour suppressor properties of miR-15a and its regulatory effects on BCL2 and SOX2 proteins in colorectal carcinomas.
    Gopalan V; Ebrahimi F; Islam F; Vider J; Qallandar OB; Pillai S; Lu CT; Lam AK
    Exp Cell Res; 2018 Sep; 370(2):245-253. PubMed ID: 29958837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in esophageal squamous cell carcinoma.
    Law FB; Chen YW; Wong KY; Ying J; Tao Q; Langford C; Lee PY; Law S; Cheung RW; Chui CH; Tsao SW; Lam KY; Wong J; Srivastava G; Tang JC
    Oncogene; 2007 Aug; 26(40):5877-88. PubMed ID: 17384685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway.
    Wang C; Wang J; Liu H; Fu Z
    Oncol Rep; 2014 May; 31(5):2270-8. PubMed ID: 24604602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-186-5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor.
    Islam F; Gopalan V; Vider J; Wahab R; Ebrahimi F; Lu CT; Kasem K; Lam AKY
    Exp Cell Res; 2017 Aug; 357(2):260-270. PubMed ID: 28549913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Expression of the YPEL3 Gene in Human Colonic Adenocarcinoma Tissue and the Effects on Proliferation, Migration, and Invasion of Colonic Adenocarcinoma Cells In Vitro via the Wnt/b-Catenin Signaling Pathway.
    Kong X; Li Y; Zhang X
    Med Sci Monit; 2018 Jul; 24():4767-4775. PubMed ID: 29988027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis.
    Mamoori A; Wahab R; Islam F; Lee K; Vider J; Lu CT; Gopalan V; Lam AK
    Hum Pathol; 2018 Jan; 71():145-156. PubMed ID: 29104111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-218 inhibits gastric tumorigenesis through regulating Bmi-1/Akt signaling pathway.
    Wu Y; Tian S; Chen Y; Ji M; Qu Y; Hou P
    Pathol Res Pract; 2019 Feb; 215(2):243-250. PubMed ID: 30420101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene amplified in oesophageal cancer 1 (GAEC1) amplification in colorectal cancers and its impact on patient's survival.
    Gopalan V; Yasuda K; Pillai S; Tiang T; Leung M; Lu CT; Tang JC; Smith RA; Lam AK
    J Clin Pathol; 2013 Aug; 66(8):721-3. PubMed ID: 23482618
    [No Abstract]   [Full Text] [Related]  

  • 14. Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.
    Li X; Zhang G; Wang Y; Elgehama A; Sun Y; Li L; Gu Y; Guo W; Xu Q
    Biomed Pharmacother; 2017 Mar; 87():366-374. PubMed ID: 28068625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel Targets.
    Penrose HM; Cable C; Heller S; Ungerleider N; Nakhoul H; Baddoo M; Hartono AB; Lee SB; Burow ME; Flemington EF; Crawford SE; Savkovic SD
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):391-408. PubMed ID: 30718226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIG1 domain family member 1A disrupts proliferation, migration, and invasion of colon adenocarcinoma cells.
    Xu Z; Sun J; Mao Y; Chen Y; Zhang T; Qin Y; Hua D
    Bioengineered; 2021 Dec; 12(2):10501-10511. PubMed ID: 34787061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of miR-152 expression suppresses cell proliferation, survival, and migration through inhibition of AKT-ERK pathway in colorectal cancer.
    Ghazanchaei A; Mansoori B; Mohammadi A; Biglari A; Baradaran B
    J Cell Physiol; 2018 Jan; 234(1):769-776. PubMed ID: 30076720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of Forkhead box A1 suppresses the tumorigenesis and progression of human colon cancer cells through regulating the phosphatase and tensin homolog/Akt pathway.
    Pan J; Xu Z; Xu M; Lin X; Lin B; Lin M
    J Int Med Res; 2020 Dec; 48(12):300060520971453. PubMed ID: 33296605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
    Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y
    Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.
    Häggblad Sahlberg S; Mortensen AC; Haglöf J; Engskog MK; Arvidsson T; Pettersson C; Glimelius B; Stenerlöw B; Nestor M
    Int J Oncol; 2017 Jan; 50(1):5-14. PubMed ID: 27878243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.